Validation of the classification criteria for cryoglobulinaemic vasculitis
The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV). Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) an...
Saved in:
Published in | Rheumatology Vol. 53; no. 12; pp. 2209 - 2213 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English Japanese |
Published |
England
Oxford University Press (OUP)
01.12.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1462-0324 1462-0332 1462-0332 |
DOI | 10.1093/rheumatology/keu271 |
Cover
Loading…
Abstract | The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).
Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria.
The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers.
Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease. |
---|---|
AbstractList | The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).
Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria.
The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers.
Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease. The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).OBJECTIVEThe aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria.METHODSTwenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria.The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers.RESULTSThe study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers.Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease.CONCLUSIONClassification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease. |
Author | Pioltelli P Gabrielli A Nishimoto N Ramos Casals M Salvarani C Ferri C Scaini P Pipitone N Cacoub P Scarpato S Voulgarelis M Pietrogrande M Salem MN Gremese E Terrier B Mazzaro C Galli M El Menyawi MA Sebastiani M Filippini D Sansonno D Guillevin L Saccardo F Monti G Tzioufas A Zoheir MN Tavoni A Retamozo S Ragab GM Fraticelli P Ferraccioli G QUARTUCCIO, Luca Tomsic M Zignego AL Bombardieri S Corazza L ISOLA, Miriam Vassilopoulos D DE VITA, Salvatore |
Author_xml | – sequence: 1 orcidid: 0000-0002-0134-6439 fullname: QUARTUCCIO, Luca – sequence: 2 orcidid: 0000-0002-6391-1720 fullname: ISOLA, Miriam – sequence: 3 fullname: Corazza L – sequence: 4 fullname: Ramos Casals M – sequence: 5 fullname: Retamozo S – sequence: 6 fullname: Ragab GM – sequence: 7 fullname: Zoheir MN – sequence: 8 fullname: El Menyawi MA – sequence: 9 fullname: Salem MN – sequence: 10 orcidid: 0000-0001-6520-1653 fullname: Sansonno D – sequence: 11 orcidid: 0000-0002-6884-4301 fullname: Ferraccioli G – sequence: 12 orcidid: 0000-0002-2248-1058 fullname: Gremese E – sequence: 13 orcidid: 0000-0001-6666-8642 fullname: Tzioufas A – sequence: 14 fullname: Voulgarelis M – sequence: 15 orcidid: 0000-0003-2288-3863 fullname: Vassilopoulos D – sequence: 16 fullname: Scarpato S – sequence: 17 fullname: Pipitone N – sequence: 18 orcidid: 0000-0001-5426-5133 fullname: Salvarani C – sequence: 19 fullname: Guillevin L – sequence: 20 fullname: Terrier B – sequence: 21 orcidid: 0000-0002-6727-4992 fullname: Cacoub P – sequence: 22 fullname: Filippini D – sequence: 23 fullname: Saccardo F – sequence: 24 fullname: Gabrielli A – sequence: 25 orcidid: 0000-0001-8220-9593 fullname: Fraticelli P – sequence: 26 orcidid: 0000-0002-1294-6421 fullname: Sebastiani M – sequence: 27 fullname: Tomsic M – sequence: 28 fullname: Tavoni A – sequence: 29 orcidid: 0000-0002-0305-6574 fullname: Mazzaro C – sequence: 30 fullname: Pioltelli P – sequence: 31 fullname: Nishimoto N – sequence: 32 fullname: Scaini P – sequence: 33 fullname: Zignego AL – sequence: 34 fullname: Ferri C – sequence: 35 fullname: Monti G – sequence: 36 fullname: Pietrogrande M – sequence: 37 fullname: Bombardieri S – sequence: 38 orcidid: 0000-0001-8887-6215 fullname: Galli M – sequence: 39 fullname: DE VITA, Salvatore |
BackLink | https://cir.nii.ac.jp/crid/1872553967477184768$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/24994905$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkEtLxDAYRYOM6Pj4BYJ04cLNaJ5Ns5TBJwNu1G1J0kSDaTMmqTD_3o4dB3HjJskN53zw3QMw6UJnADhB8AJBQS7jm-lbmYMPr6vLd9NjjnbAFNESzyAheLJ9Y7oPjlNyCkJIuYCo2gP7mApBBWRT8PAivWtkdqErgi3ymym0lwNvnR5_dXTZRCcLG-IQVuHVB9V710nTOl18yqSHlF06ArtW-mSON_cheL65fprfzRaPt_fzq8VMUwjzzEBKGtzwyirEDWs0ZQgJpiimCDFuK6KkqaglJbPElI2iSJSqolSVQkHNySE4H-cuY_joTcp165I23svOhD7VqMRcMMgIHNDTDdqr1jT1MrpWxlX9s_8AkBHQMaQUjd0iCNbrouvfRddj0YMl_lja5e-2cpTO_-OejW7n3KCtT1RxzBgRJaeco4rysiJfF9CU5g |
CitedBy_id | crossref_primary_10_1016_j_medcli_2021_11_017 crossref_primary_10_1016_j_autrev_2016_09_006 crossref_primary_10_1016_j_jare_2016_11_002 crossref_primary_10_1002_hep_32281 crossref_primary_10_1016_j_jare_2016_02_006 crossref_primary_10_1093_rheumatology_kew194 crossref_primary_10_3389_fcvm_2021_744648 crossref_primary_10_1016_j_aohep_2019_04_010 crossref_primary_10_1007_s00393_017_0356_7 crossref_primary_10_1016_j_rbr_2017_07_510 crossref_primary_10_1016_j_semarthrit_2020_07_013 crossref_primary_10_1371_journal_pone_0117420 crossref_primary_10_30841_2307_5112_4_2019_184366 crossref_primary_10_1080_1744666X_2023_2249609 crossref_primary_10_1016_j_medcle_2021_11_009 crossref_primary_10_1038_s41598_024_60490_z crossref_primary_10_4103_1319_2442_394001 crossref_primary_10_1002_art_41434 crossref_primary_10_1007_s11739_017_1683_z crossref_primary_10_1016_j_rdc_2014_09_008 crossref_primary_10_1080_1744666X_2019_1649596 crossref_primary_10_3390_jcm14020556 crossref_primary_10_1093_ndt_gfv335 crossref_primary_10_1007_s00393_016_0076_4 crossref_primary_10_3389_fimmu_2024_1385086 crossref_primary_10_1111_apt_14845 crossref_primary_10_1097_RHU_0000000000001041 crossref_primary_10_1007_s11926_015_0526_z crossref_primary_10_1186_s44158_024_00141_x crossref_primary_10_3390_jcm13206069 crossref_primary_10_1016_j_ajg_2018_06_003 crossref_primary_10_1016_j_nephro_2016_01_010 crossref_primary_10_1111_cei_12690 crossref_primary_10_23736_S0026_4806_24_09170_5 crossref_primary_10_1038_s41572_018_0009_4 crossref_primary_10_1016_j_autrev_2022_103034 crossref_primary_10_1038_nrdp_2016_47 crossref_primary_10_14309_ajg_0000000000001667 crossref_primary_10_1016_j_ejr_2018_01_001 crossref_primary_10_23736_S0026_4806_20_07158_X crossref_primary_10_1007_s10067_021_06032_8 crossref_primary_10_1186_s13075_017_1280_6 crossref_primary_10_1016_j_berh_2018_10_003 crossref_primary_10_1080_17512433_2017_1357466 crossref_primary_10_1002_acr_23770 crossref_primary_10_1080_1744666X_2019_1656527 crossref_primary_10_3389_fimmu_2021_580271 crossref_primary_10_1016_j_ebiom_2018_08_007 crossref_primary_10_1080_14728214_2019_1634052 crossref_primary_10_1097_BOR_0000000000000757 crossref_primary_10_1007_s10875_023_01444_4 crossref_primary_10_1136_bcr_2018_229059 crossref_primary_10_1111_nan_12413 crossref_primary_10_1155_2022_9171284 crossref_primary_10_1007_s00296_018_4192_0 crossref_primary_10_3389_fimmu_2024_1450048 crossref_primary_10_1016_j_transci_2018_06_005 crossref_primary_10_1016_j_autrev_2021_102923 crossref_primary_10_1016_j_monrhu_2017_04_004 |
Cites_doi | 10.1136/ard.2011.150755 10.1002/art.1780341221 10.1093/rheumatology/kem209 10.1002/art.27584 10.1136/jcp.55.1.4 10.1016/0002-9343(66)90199-9 10.1136/annrheumdis-2013-204424 10.1002/art.23015 10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8 10.1002/art.23018 10.1056/NEJM199211193272104 |
ContentType | Journal Article |
Contributor | Saccardo, Francesco De Vita, Salvatore Zignego, ANNA LINDA Zoheir, Mostafa N. aguib Scarpato, Salvatore Pioltelli, Pietro Bombardieri, Stefano Guillevin, Loic Ramos Casals, Manuel Sebastiani, Marco Ferri, Clodoveo Filippini, Davide Cacoub, Patrice Tomsic, Matija Pipitone, Nicolò Galli, Massimo Mazzaro, Cesare Sansonno, Domenico Ettore Scaini, Patrizia Corazza, Laura Ragab, Gaafar M. ohamed Salem, Mohamed N. abil Quartuccio, Luca Voulgarelis, Michael Monti, Giuseppe Vassilopoulos, Dimitri Pietrogrande, Maurizio Retamozo, Soledad Ferraccioli, Gianfranco Nishimoto, Norihiro Gremese, Elisa Gabrielli, Armando Tzioufas, Athanasio Tavoni, Antonio Isola, Miriam Salvarani, Carlo Fraticelli, Paolo El Menyawi, Manal A. bdel Moneim Terrier, Benjamin |
Contributor_xml | – sequence: 1 fullname: Quartuccio, Luca – sequence: 2 fullname: Isola, Miriam – sequence: 3 fullname: Corazza, Laura – sequence: 4 fullname: Ramos Casals, Manuel – sequence: 5 fullname: Retamozo, Soledad – sequence: 6 fullname: Ragab, Gaafar M. ohamed – sequence: 7 fullname: Zoheir, Mostafa N. aguib – sequence: 8 fullname: El Menyawi, Manal A. bdel Moneim – sequence: 9 fullname: Salem, Mohamed N. abil – sequence: 10 fullname: Sansonno, Domenico Ettore – sequence: 11 fullname: Ferraccioli, Gianfranco – sequence: 12 fullname: Gremese, Elisa – sequence: 13 fullname: Tzioufas, Athanasio – sequence: 14 fullname: Voulgarelis, Michael – sequence: 15 fullname: Vassilopoulos, Dimitri – sequence: 16 fullname: Scarpato, Salvatore – sequence: 17 fullname: Pipitone, Nicolò – sequence: 18 fullname: Salvarani, Carlo – sequence: 19 fullname: Guillevin, Loic – sequence: 20 fullname: Terrier, Benjamin – sequence: 21 fullname: Cacoub, Patrice – sequence: 22 fullname: Filippini, Davide – sequence: 23 fullname: Saccardo, Francesco – sequence: 24 fullname: Gabrielli, Armando – sequence: 25 fullname: Fraticelli, Paolo – sequence: 26 fullname: Sebastiani, Marco – sequence: 27 fullname: Tomsic, Matija – sequence: 28 fullname: Tavoni, Antonio – sequence: 29 fullname: Mazzaro, Cesare – sequence: 30 fullname: Pioltelli, Pietro – sequence: 31 fullname: Nishimoto, Norihiro – sequence: 32 fullname: Scaini, Patrizia – sequence: 33 fullname: Zignego, ANNA LINDA – sequence: 34 fullname: Ferri, Clodoveo – sequence: 35 fullname: Monti, Giuseppe – sequence: 36 fullname: Pietrogrande, Maurizio – sequence: 37 fullname: Bombardieri, Stefano – sequence: 38 fullname: Galli, Massimo – sequence: 39 fullname: De Vita, Salvatore |
Copyright | The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1093/rheumatology/keu271 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1462-0332 |
EndPage | 2213 |
ExternalDocumentID | 24994905 10_1093_rheumatology_keu271 |
Genre | Validation Studies Multicenter Study Journal Article |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29P 2WC 354 4.4 48X 53G 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWTL ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABVGC ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGORE AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MHKGH N9A NGC NOMLY NOYVH NU- NVLIB O9- OAUYM OAWHX OBH OCZFY ODMLO OHH OJQWA OJZSN OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX RUSNO RW1 RXO RYH SV3 TCURE TEORI TJX TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ZY1 ~91 AAYXX CITATION .GJ 3O- AAGKA AAPGJ AAWDT ABNGD ACFRR ACUKT ADMTO AEHUL AFFNX AGQPQ AHGBF AQDSO ATTQO AZFZN CAG CGR COF CUY CVF ECM EIF EIHJH FEDTE HVGLF NPM NTWIH O0~ O~Y PB- RIG RNI RZF RZO TMA ZGI 7X8 |
ID | FETCH-LOGICAL-c400t-e043d2d78fb17e5dc451195b4241157f83bae84f365f3e6db4196b844b69b0c73 |
ISSN | 1462-0324 1462-0332 |
IngestDate | Fri Jul 11 02:20:59 EDT 2025 Mon Jul 21 05:30:22 EDT 2025 Tue Jul 01 01:36:31 EDT 2025 Thu Apr 24 22:52:05 EDT 2025 Thu Jun 26 23:26:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | classification vasculitis cryoglobulinaemia hepatitis C |
Language | English Japanese |
License | The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c400t-e043d2d78fb17e5dc451195b4241157f83bae84f365f3e6db4196b844b69b0c73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-1294-6421 0000-0001-6666-8642 0000-0002-6884-4301 0000-0001-6520-1653 0000-0002-2248-1058 0000-0001-8220-9593 0000-0001-5426-5133 0000-0002-0305-6574 0000-0002-6391-1720 0000-0002-0134-6439 0000-0002-6727-4992 0000-0003-2288-3863 0000-0001-8887-6215 |
OpenAccessLink | https://cir.nii.ac.jp/crid/1872553967477184768 |
PMID | 24994905 |
PQID | 1627950530 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1627950530 pubmed_primary_24994905 crossref_primary_10_1093_rheumatology_keu271 crossref_citationtrail_10_1093_rheumatology_keu271 nii_cinii_1872553967477184768 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-12-01 |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Rheumatology |
PublicationTitleAlternate | Rheumatology (Oxford) |
PublicationYear | 2014 |
Publisher | Oxford University Press (OUP) |
Publisher_xml | – name: Oxford University Press (OUP) |
References | Brouet ( key 20170522164521_keu271-B8) 1974; 57 Ferri ( key 20170522164521_keu271-B12) 2002; 55 Johnson ( key 20170522164521_keu271-B10) 2007; 57 Gorevic ( key 20170522164521_keu271-B2) 1991; 28 Meltzer ( key 20170522164521_keu271-B1) 1966; 40 De Vita ( key 20170522164521_keu271-B7) 2011; 70 Quartuccio ( key 20170522164521_keu271-B14) 2012; 30 Agnello ( key 20170522164521_keu271-B5) 1992; 327 Quartuccio ( key 20170522164521_keu271-B6) 2007; 46 De Vita ( key 20170522164521_keu271-B13) 2011; 29 van den Hoogen ( key 20170522164521_keu271-B16) 2013; 72 Aletaha ( key 20170522164521_keu271-B15) 2010; 62 Ferri ( key 20170522164521_keu271-B4) 1991; 34 Invernizzi ( key 20170522164521_keu271-B11) 1995; 13 Dougados ( key 20170522164521_keu271-B9) 2007; 57 De Vita ( key 20170522164521_keu271-B3) 2000; 43 |
References_xml | – volume: 70 start-page: 1183 year: 2011 ident: key 20170522164521_keu271-B7 article-title: Preliminary classification criteria for the cryoglobulinaemic vasculitis publication-title: Ann Rheum Dis doi: 10.1136/ard.2011.150755 – volume: 34 start-page: 1606 year: 1991 ident: key 20170522164521_keu271-B4 article-title: Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia publication-title: Arthritis Rheum doi: 10.1002/art.1780341221 – volume: 13 start-page: S123 year: 1995 ident: key 20170522164521_keu271-B11 article-title: Classification of the cryoglobulinemic syndrome publication-title: Clin Exp Rheumatol – volume: 46 start-page: 1657 year: 2007 ident: key 20170522164521_keu271-B6 article-title: Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis publication-title: Rheumatology doi: 10.1093/rheumatology/kem209 – volume: 28 start-page: 79 year: 1991 ident: key 20170522164521_keu271-B2 article-title: Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases publication-title: Semin Hematol – volume: 62 start-page: 2569 year: 2010 ident: key 20170522164521_keu271-B15 article-title: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Arthritis Rheum doi: 10.1002/art.27584 – volume: 55 start-page: 4 year: 2002 ident: key 20170522164521_keu271-B12 article-title: Cryoglobulins publication-title: J Clin Pathol doi: 10.1136/jcp.55.1.4 – volume: 40 start-page: 828 year: 1966 ident: key 20170522164521_keu271-B1 article-title: Cryoglobulinemia—a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability publication-title: Am J Med doi: 10.1016/0002-9343(66)90199-9 – volume: 30 start-page: S48 year: 2012 ident: key 20170522164521_keu271-B14 article-title: Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis publication-title: Clin Exp Rheumatol – volume: 72 start-page: 1747 year: 2013 ident: key 20170522164521_keu271-B16 article-title: 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204424 – volume: 29 start-page: S99 year: 2011 ident: key 20170522164521_keu271-B13 article-title: Treatment of mixed cryoglobulinemia: a rheumatology perspective publication-title: Clin Exp Rheumatol – volume: 57 start-page: 1112 year: 2007 ident: key 20170522164521_keu271-B9 article-title: Classification criteria for rheumatic disease: why and how? publication-title: Arthritis Rheum doi: 10.1002/art.23015 – volume: 57 start-page: 775 year: 1974 ident: key 20170522164521_keu271-B8 article-title: Biologic and clinical significance of cryoglobulins publication-title: A report of 86 cases. Am J Med – volume: 43 start-page: 94 year: 2000 ident: key 20170522164521_keu271-B3 article-title: Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8 – volume: 57 start-page: 1119 year: 2007 ident: key 20170522164521_keu271-B10 article-title: Classification criteria in rheumatic diseases: a review of methodologic properties publication-title: Arthritis Rheum doi: 10.1002/art.23018 – volume: 327 start-page: 1490 year: 1992 ident: key 20170522164521_keu271-B5 article-title: A role for hepatitis C virus infection in type II cryoglobulinemia publication-title: N Engl J Med doi: 10.1056/NEJM199211193272104 |
SSID | ssib000479018 ssib000588979 ssib000829807 ssib058575242 ssib017358208 ssib024195679 ssib032048062 ssib008873835 ssib007540058 ssj0005138 |
Score | 2.4062934 |
Snippet | The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).
Twenty-three centres were involved. New patients with... The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).OBJECTIVEThe aim of this study was to validate the... |
SourceID | proquest pubmed crossref nii |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2209 |
SubjectTerms | Adult Aged Case-Control Studie Case-Control Studies classification classification; cryoglobulinaemia; hepatitis C; vasculitis; Adult; Aged; Case-Control Studies; Cryoglobulinemia; Female; Hepatitis C; Humans; Male; Middle Aged; Questionnaires; Sensitivity and Specificity; Systemic Vasculitis; Medicine (all) classification; cryoglobulinaemia; hepatitis C; vasculitis; Adult; Aged; Case-Control Studies; Cryoglobulinemia; Female; Hepatitis C; Humans; Male; Middle Aged; Sensitivity and Specificity; Surveys and Questionnaires; Systemic Vasculitis; Medicine (all) cryoglobulinaemia Cryoglobulinemia Cryoglobulinemia - classification Cryoglobulinemia - complications Cryoglobulinemia - diagnosis Female Hepatitis C Hepatitis C - complications hepatitis C virus; Mixed Cryoglobulinemia; cryoglobulinemic vasculitis; classification Human Humans Male Medicine (all) Middle Aged Questionnaires Sensitivity and Specificity Surveys and Questionnaire Surveys and Questionnaires Systemic Vasculiti Systemic Vasculitis Systemic Vasculitis - classification Systemic Vasculitis - diagnosis Systemic Vasculitis - etiology vasculiti vasculitis |
Title | Validation of the classification criteria for cryoglobulinaemic vasculitis |
URI | https://cir.nii.ac.jp/crid/1872553967477184768 https://www.ncbi.nlm.nih.gov/pubmed/24994905 https://www.proquest.com/docview/1627950530 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXYkBAvE990MBQkHglLbOfrEU0bY-qGNLWob1H8Ea2CJahtJOiv59hO0lQbaPAStVdxnPheXZ1rHx8T8o6qNBZKpL5E-eFzLpWfZmEGIKeE1kkcFVZ4_vwiPp3ys1k0WGi3u0tW4oNc37qv5H-8Chv8anbJ_oNn-4fCgN_wL67wMK538vFXgGjVYz4DIaUBw4b946xICUaLubBkQrn4VRv9D8M9Lywn3tFQjarREKNeXukGONaJMxk10p8dAb498WMwe2A5oY2UczvjOm42xJ_P-PTCEfPxAtf9WgdCbr0uui3Z_e2XxXW99I-KJQbN7SGqmpbN385JhHzA73BplMcwsHbmUt9ia3OvEwruYowOMym1sgk3U7yTv1oMhgJ_v-mGuqNctiW1L77kJ9PxOJ8czyY75D5FLWGOufg0G_CAQnvcef96nTRVxg6HnRy6Lrbgy041n_-5MrEIZfKI7LWlhffRxcljck9XT8iD85Y88ZScbcLFq0sP4eJth4vXhYsHh3s3wsXbhMszMj05nhyd-u1RGr5Ekl75OuBMUZWkpQgTHSlpZOmySHAAuDBKypSJQqe8ZHFUMh0rwZGZRcq5iDMRyIQ9J7tVXemXxJPAqAplNU1EyWWBhirQgYBJBaVm4YjQboRy2erMm-NOvueO78Dy4bDmblhH5H3f6IeTWfn77QcYejzeXMM0QV3MshiVMZAWRwE9Im87p-RIl2YNrKh03SzzMKZJBtTPghF54bzVd0hR_fMsiPbv0PoVebgJ_Ndkd7Vo9AHg6Uq8seH1Gz8Flkg |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+the+classification+criteria+for+cryoglobulinaemic+vasculitis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Quartuccio%2C+Luca&rft.au=Isola%2C+Miriam&rft.au=Corazza%2C+Laura&rft.au=Ramos-Casals%2C+Manuel&rft.date=2014-12-01&rft.issn=1462-0332&rft.eissn=1462-0332&rft.volume=53&rft.issue=12&rft.spage=2209&rft_id=info:doi/10.1093%2Frheumatology%2Fkeu271&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon |